Mexico Non-steroidal Anti-inflammatory Drugs Market Size & Outlook
The non-steroidal anti-inflammatory drugs market in Mexico is expected to reach a projected revenue of US$ 115.6 million by 2030. A compound annual growth rate of 6.8% is expected of Mexico non-steroidal anti-inflammatory drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$78.3
Forecast, 2030 (US$M)
$115.6
CAGR, 2025 - 2030
6.8%
Report Coverage
Mexico
Mexico non-steroidal anti-inflammatory drugs market, 2018-2030 (US$M)
Related Markets
Mexico non-steroidal anti-inflammatory drugs market highlights
- The Mexico non-steroidal anti-inflammatory drugs market generated a revenue of USD 78.3 million in 2024 and is expected to reach USD 115.6 million by 2030.
- The Mexico market is expected to grow at a CAGR of 6.8% from 2025 to 2030.
- In terms of segment, arthritis was the largest revenue generating disease indication in 2024.
- Migraine is the most lucrative disease indication segment registering the fastest growth during the forecast period.
Non-steroidal anti-inflammatory drugs market data book summary
| Market revenue in 2024 | USD 78.3 million |
| Market revenue in 2030 | USD 115.6 million |
| Growth rate | 6.8% (CAGR from 2025 to 2030) |
| Largest segment | Arthritis |
| Fastest growing segment | Migraine |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Arthritis, Migraine, Ophthalmic Diseases |
| Key market players worldwide | Pfizer Inc, Bayer AG, GSK PLC ADR, Dr Reddy's Laboratories Ltd ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd ADR, Johnson & Johnson, Merck & Co Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.3% of the global non-steroidal anti-inflammatory drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. non-steroidal anti-inflammatory drugs market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 115.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-steroidal Anti-inflammatory Drugs Market Scope
Non-steroidal anti-inflammatory drugs market segmentation & scope
Non-steroidal Anti-inflammatory Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico non-steroidal anti-inflammatory drugs market size, by disease indication, 2018-2030 (US$M)
Mexico Non-steroidal Anti-inflammatory Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
